2022 - RMB Corvest and Umoya Capital Partners invested in Brunel
RMB Corvest and Umoya Capital Partners a private equity consortium , alongside management and Calibre Capital, invested in Brunel Laboratoria (Pty) Ltd, strengthening the company’s financial position and supporting its long-term growth strategy.
2022 to present - Brunel continues to grow and expand
Brunel has continued to scale its operations, invest in infrastructure, and expand its product portfolio to meet the evolving needs of the South African healthcare sector. Operating from a custom-built, temperature- and access-controlled facility, Brunel manages a comprehensive portfolio that includes pharmaceuticals, complementary medicines, personal care products, and healthcare consumables.